Sign in
4

Changes in Ownership

Rapport Therapeutics, Inc. Filed Acc 0001193125-26-304786

Chief Executive Officer sold 8,210 shares at an average $40.00 ($328,437)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ceesay Abraham Chief Executive Officer 2026-07-14 Sale 10b5-1 −5,481 $39.72 $217,715 542,546 D
Ceesay Abraham Chief Executive Officer 2026-07-14 Sale 10b5-1 −2,729 $40.57 $110,722 539,817 D
Open-market sales · 8,210 sh · avg $40.00 · $328,437
Loading xslF345X06/ownership.xml…